Showing results (171-180 of 255) with videos related to

Sort By:
Pageof 26
Molecular Imaging and Biology|October 17, 2014
SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine TumorsC Kratochwil, M Stefanova, E Mavriopoulou, et al.
Cellular Immunology|December 31, 2020
Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot studyChristoffer Gebhardt, Sonja C S Simon, Rebekka Weber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2017
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with <sup>131</sup>I-MIP-1095Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, et al.
The American Journal of Gastroenterology|December 14, 2007
Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis genePeter Felderbauer, Elias Karakas, Volker Fendrich, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 24, 2010
Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditionsJ M Hohlfeld, T Holland-Letz, M Larbig, et al.
Journal of Autoimmunity|October 13, 2022
Induction of cross-reactive, mucosal anti-SARS-CoV-2 antibody responses in rheumatoid arthritis patients after 3rd dose of COVID-19 vaccinationM Bondareva, P Letz, K Karberg, et al.
International Journal of Molecular Sciences|March 23, 2018
Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control IndividualsXue Cao, Qiuqiong Tang, Tim Holland-Letz, et al.
Vascular Medicine (London, England)|July 10, 2007
Reproducibility and reliability of the ankle-brachial index as assessed by vascular experts, family physicians and nursesTim Holland-Letz, Heinz G Endres, Stefanie Biedermann, et al.
The Journal of Clinical Endocrinology and Metabolism|July 30, 2010
Novel activating mutations of the calcium-sensing receptor: the calcilytic NPS-2143 mitigates excessive signal transduction of mutant receptorsSaskia Letz, Ramona Rus, Christine Haag, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Response Prediction of <sup>177</sup>Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate DehydrogenaseHendrik Rathke, Tim Holland-Letz, Walter Mier, et al.
Pageof 26